Factor VIIa recombinante (rFVIIa). Descripción de uso en una cohorte de enfermos críticos y marcadores pronósticos

The present series of cases, with the disadvantage of its heterogeneity and the limited number of patients, stresses the role of hemodynamic improvement as a differentiating factor between those patients who survive and those who do not.